Sponsor: Opioid Response Network in collaboration with the American Psychiatric Nurses Association
This presentation will explore how substance use during pregnancy impacts the maternal/fetal development and increases the neurological vulnerabilities of the neonate. The unique challenges and opportunities of providing care to a substance-exposed pregnancy will be explored. The importance of screening procedures will be discussed and how the information obtained during the screening influences the treatment plan.
Presenter: Kathleen Schachman, PhD, PMHNP-BC, FAANP, FIAAN
For more information and to register click here
Upon completion of this presentation, the participant will be able to:
- Describe two ways that substance use during pregnancy impacts maternal/fetal developmental and neurological vulnerabilities of the neonate.
- Identify the unique challenges and opportunities in providing care for substance-exposed pregnancies.
- Implement screening procedures identify high-risk or problematic substance use during pregnancy.
- Plan treatment approaches to optimize maternal and neonatal outcomes.
This is an open ended event